Vimarsana
Biggest News Aggregation in the World

Page 31 - Management Ltd News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Management Ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Management Ltd Today - Breaking & Trending Today

Vertiv (NYSE:VRT) Trading 11.7% Higher After Strong Earnings - Vimarsana News

Vertiv (NYSE:VRT) Trading 11.7% Higher After Strong Earnings

Vertiv Holdings Co (NYSE:VRT – Get Free Report) shot up 11.7% during mid-day trading on Wednesday after the company announced better than expected quarterly earnings. The company traded as high as $94.39 and last traded at $88.45. 12,267,756 shares were traded during trading, an increase of 60% from the average session volume of 7,676,429 shares. […]

Top 7 Mutual Funds Up To 73% Returns In 1 Year; Check Interest On Small Cap MFs - Vimarsana News

Top 7 Mutual Funds Up To 73% Returns In 1 Year; Check Interest On Small Cap MFs

Bandhan Small Cap Fund, Quant Small Cap Fund, Invesco India Small Cap Fund are some of the top performing mutual funds in the small cap segment in the last one year.  Check more on returns or interest on these small-cap mutual funds.

Source: india.com
Pagabo reveals 56 winners of latest £1.6bn retrofit deal - Vimarsana News

Pagabo reveals 56 winners of latest £1.6bn retrofit deal

Decarbonisation Solutions Framework launched: Full list of winners

Zydus gets China nod for kidney disease drug - Vimarsana News

Zydus gets China nod for kidney disease drug

Ahmedabad-based Zydus Lifesciences said on Tuesday that a new drug application for its oral drug Desidustat used in treating anaemia in chronic kidney disease (CKD) patients had been accepted by the National Medical Products Administration of China (NMPA). In 2020, CMS International Development and Management Ltd, a wholly-owned subsidiary of China Medical System Holdings Ltd obtained an exclusive license for the product from Zydus. CKD involves a gradual loss of functioning of kidneys and eventually leads to kidney failure.

Source: rediff.com
New Oriental Education & Technology Group (NYSE:EDU) Shares Gap Down to $89.59 - Vimarsana News

New Oriental Education & Technology Group (NYSE:EDU) Shares Gap Down to $89.59

New Oriental Education & Technology Group Inc. (NYSE:EDU – Get Free Report) shares gapped down prior to trading on Wednesday . The stock had previously closed at $89.59, but opened at $84.54. New Oriental Education & Technology Group shares last traded at $73.90, with a volume of 3,153,898 shares traded. Analyst Upgrades and Downgrades Several […]

Source: wkrb13.com